Prognostic factors in melanoma

被引:7
作者
Kycler, Witold [1 ]
Grodecka-Gazdecka, Sylwia [2 ]
Breborowicz, Jan [2 ]
Filas, Violetta [2 ]
Teresiak, Marek [1 ]
机构
[1] Great Poland Canc Ctr, Dept Oncol Surg 2, Garbary 15 Str, PL-61866 Poznan, Poland
[2] Poznan Univ Med Sci, Oncol Dept, Poznan, Poland
关键词
malignant melanoma; prognostic factors; immunohistochemistry;
D O I
10.1016/S1507-1367(06)71048-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background There are clinical and pathological factors associated with the clinical course of melanoma. These parameters allow us to predict survival times and establish a course of treatment. Aim The aim of the study was to assess the significance of immunohistochemical markers in the progression of melanoma, and relate these findings to the influence of clinical and histological factors on survival time. Materials/Methods In this study, archival histological material obtained from 50 melanoma patients operated on in the Great Poland Cancer Centre between 1990-1995 was analysed. Using immunohistochemistry we detected the presence of markers known to be important in the diagnosis of melanoma, including: HMB-45, PCNA, Ki-67, MMP-2, CD44 and nm23. Following this, univariate logistic regression was performed and clinical, histopathological and immunohistochemical data of statistical significance were correlated with survival time using the Cox nonparametric proportional hazard regression model. Results The results suggested that the most important prognostic factors correlating with survival time were: the presence of nm23 antigen (p=0.0342) and the thickness of the melanoma, as measured by the Breslow method in mm (p=0.0191). According to the univariate analysis there were correlations between patient death or survival and the histological type, Superficial Spreading Melanoma Malignum (SSMM) (p=0.0187), regional lymphatic metastases (p=0.0030) and positive Ki-67 results (p=0.0282). Conclusion Taken together, our results allowed us to conclude (a) that there was a correlation between survival time and nm23 antigen expression and the thickness of melanoma, as measured by the Breslow method in mm, (b) that there were correlations between patient survival or death and the histological type of Superficial Spreading Melanoma Malignum, regional lymphatic metastases and positive Ki-67, (c) that other parameters (age, gender, anatomical location of the melanoma, the presence of ulceration, lymphatic infiltration, the existence of satellites, and positive PCNA and MN IP-2) showed no significant influence on survival.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 39 条
  • [1] Malignant melanoma: Prognostic indicators
    Ahmed, I
    [J]. MAYO CLINIC PROCEEDINGS, 1997, 72 (04) : 356 - 361
  • [2] CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation
    Ahrens, T
    Assmann, V
    Fieber, C
    Termeer, CC
    Herrlich, P
    Hofmann, M
    Simon, JC
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (01) : 93 - 101
  • [3] Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment
    Ak, I
    Stokkel, MPM
    Bergman, W
    Pauwels, EKJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (04) : 347 - 358
  • [4] Skin melanoma in Italy: a population-based study on survival and prognostic factors
    Balzi, D
    Carli, P
    Giannotti, B
    Buiatti, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) : 699 - 704
  • [5] BARNES R, 1991, AM J PATHOL, V139, P245
  • [6] Betke Herbert, 1998, Polish Journal of Pathology, V49, P93
  • [7] Bodey B, 1997, ANTICANCER RES, V17, P505
  • [8] Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO
  • [9] 2-0
  • [10] FLORENES VA, 1992, CANCER RES, V52, P6088